nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Clever Person Solves a Problem; a Wise Person Avoids It
|
Tichelli, André |
|
2013 |
19 |
7 |
p. 1004-1005 2 p. |
artikel |
2 |
A French Cohort of Childhood Leukemia Survivors: Impact of Hematopoietic Stem Cell Transplantation on Health Status and Quality of Life
|
Berbis, Julie |
|
2013 |
19 |
7 |
p. 1065-1072 8 p. |
artikel |
3 |
Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated with High-Risk Pediatric Acute Myeloid Leukemia
|
Burke, Michael J. |
|
2013 |
19 |
7 |
p. 1021-1025 5 p. |
artikel |
4 |
Allotype Analysis to Distinguish the Origin of Varicella-Zoster Virus Immunoglobulin G after Allogeneic Stem Cell Transplantation
|
Yamazaki, Rie |
|
2013 |
19 |
7 |
p. 1013-1020 8 p. |
artikel |
5 |
A Phase I Study of CPX-351 in Combination with Busulfan and Fludarabine Conditioning and Allogeneic Stem Cell Transplantation in Adult Patients with Refractory Acute Leukemia
|
Gergis, Usama |
|
2013 |
19 |
7 |
p. 1040-1045 6 p. |
artikel |
6 |
ASBMT News
|
|
|
2013 |
19 |
7 |
p. 1136- 1 p. |
artikel |
7 |
Autologous Umbilical Cord Blood Infusion followed by Oral Docosahexaenoic Acid and Vitamin D Supplementation for C-Peptide Preservation in Children with Type 1 Diabetes
|
Haller, Michael J. |
|
2013 |
19 |
7 |
p. 1126-1129 4 p. |
artikel |
8 |
Burden of Morbidity in 10+ Year Survivors of Hematopoietic Cell Transplantation: Report from the Bone Marrow Transplantation Survivor Study
|
Sun, Can-Lan |
|
2013 |
19 |
7 |
p. 1073-1080 8 p. |
artikel |
9 |
Cyclophosphamide followed by Intravenous Targeted Busulfan for Allogeneic Hematopoietic Cell Transplantation: Pharmacokinetics and Clinical Outcomes
|
Rezvani, Andrew R. |
|
2013 |
19 |
7 |
p. 1033-1039 7 p. |
artikel |
10 |
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
|
Kharfan-Dabaja, Mohamed A. |
|
2013 |
19 |
7 |
p. 1006-1012 7 p. |
artikel |
11 |
Editorial Board
|
|
|
2013 |
19 |
7 |
p. A3- 1 p. |
artikel |
12 |
Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors
|
Hirokawa, Makoto |
|
2013 |
19 |
7 |
p. 1026-1032 7 p. |
artikel |
13 |
Extracorporeal Photopheresis versus Anticytokine Therapy as a Second-Line Treatment for Steroid-Refractory Acute GVHD: A Multicenter Comparative Analysis
|
Jagasia, Madan |
|
2013 |
19 |
7 |
p. 1129-1133 5 p. |
artikel |
14 |
Hematopoietic Cell Transplantation in High-Risk Childhood Acute Myelogenous Leukemia
|
Meshinchi, Soheil |
|
2013 |
19 |
7 |
p. 1002-1003 2 p. |
artikel |
15 |
John H. Kersey, M.D.
|
Weisdorf, Daniel J. |
|
2013 |
19 |
7 |
p. 1001- 1 p. |
artikel |
16 |
Masthead (Purpose and Scope)
|
|
|
2013 |
19 |
7 |
p. A2- 1 p. |
artikel |
17 |
Molecular Monitoring of Minimal Residual Disease in the Peripheral Blood of Patients with Multiple Myeloma
|
Korthals, Mark |
|
2013 |
19 |
7 |
p. 1109-1115 7 p. |
artikel |
18 |
Motivations, Experiences, and Perspectives of Bone Marrow and Peripheral Blood Stem Cell Donors: Thematic Synthesis of Qualitative Studies
|
Garcia, Maria C. |
|
2013 |
19 |
7 |
p. 1046-1058 13 p. |
artikel |
19 |
Nelarabine for T Cell Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: An Opportunity to Improve Survival
|
Forcade, Edouard |
|
2013 |
19 |
7 |
p. 1124-1126 3 p. |
artikel |
20 |
Officers and Directors of ASBMT
|
|
|
2013 |
19 |
7 |
p. A4- 1 p. |
artikel |
21 |
Outcomes of Adults with Acute Lymphoblastic Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
|
Poon, Li Mei |
|
2013 |
19 |
7 |
p. 1059-1064 6 p. |
artikel |
22 |
Phase II Study of CD4+-Guided Pentostatin Lymphodepletion and Pharmacokinetically Targeted Busulfan as Conditioning for Hematopoietic Cell Allografting
|
Kharfan-Dabaja, Mohamed A. |
|
2013 |
19 |
7 |
p. 1087-1093 7 p. |
artikel |
23 |
Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation
|
Kumar, Anita J. |
|
2013 |
19 |
7 |
p. 1094-1101 8 p. |
artikel |
24 |
Relationship of Body Mass Index and Arm Anthropometry to Outcomes after Pediatric Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
|
Hoffmeister, Paul A. |
|
2013 |
19 |
7 |
p. 1081-1086 6 p. |
artikel |
25 |
Salvage Bone Marrow Harvest in Patients Failing Plerixafor-Based Stem Cell Mobilization Attempt: Feasibility and Autologous Transplantation Outcomes
|
Kanate, Abraham S. |
|
2013 |
19 |
7 |
p. 1133-1135 3 p. |
artikel |
26 |
Table of Contents
|
|
|
2013 |
19 |
7 |
p. A7-A10 nvt p. |
artikel |
27 |
Trends in Use of and Survival after Autologous Hematopoietic Cell Transplantation in North America, 1995-2005: Significant Improvement in Survival for Lymphoma and Myeloma during a Period of Increasing Recipient Age
|
McCarthy Jr., Philip L. |
|
2013 |
19 |
7 |
p. 1116-1123 8 p. |
artikel |
28 |
Unrelated Donor Allogeneic Transplantation after Failure of Autologous Transplantation for Acute Myelogenous Leukemia: A Study from the Center for International Blood and Marrow Transplantation Research
|
Foran, James M. |
|
2013 |
19 |
7 |
p. 1102-1108 7 p. |
artikel |